Gambaran Lama Rawat Inap Pasien Pneumonia Balita Berdasarkan Jenis Terapi Antibiotik di Rumah Sakit X Jakarta
DOI:
https://doi.org/10.31004/joecy.v5i2.2588Keywords:
pneumonia, toddlers, single antibiotics, combination antibiotics, length of hospitalizationAbstract
Pneumonia is one of the leading causes of morbidity and mortality in infants in Indonesia. Antibiotic therapy is a key component of its treatment. However, the choice between single antibiotic therapy and combination therapy remains a subject of debate, particularly in relation to efficiency and length of hospital stay. This study aims to compare the length of hospital stay in infants with pneumonia who received single antibiotic therapy and combination antibiotic therapy at Hospital X. The study employs a quantitative observational design with a retrospective approach. Data were collected from medical records of pediatric pneumonia patients during a specific period at Hospital X, with 44 patients receiving single antibiotic therapy and 6 patients receiving combination therapy. Data analysis was performed using the non-parametric Mann–Whitney test to compare hospitalization duration between the two therapy groups. The results of the Mann–Whitney test showed no significant difference in the length of hospital stay between patients receiving monotherapy and combination therapy (p = 0.214; p ≥ 0.05). This indicates that monotherapy provides clinically comparable outcomes to combination therapy in terms of length of hospital stay. Single antibiotic therapy was found to be comparable in effectiveness to combination therapy in terms of length of hospital stay in infants with pneumonia. These results support the application of rational antibiotic therapy principles and provide a basis for the efficient use of antibiotics.
References
Adnan, S., Paterson, D. L., Lipman, J., & Roberts, J. A. (2013). Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients. International Journal of Antimicrobial Agents, 42(5), 384–389. https://doi.org/10.1016/j.ijantimicag.2013.07.012
Alcón, A., Fàbregas, N., & Torres, A. (2005). Pathophysiology of pneumonia. Clinics in Chest Medicine, 26(1), 39–46. https://doi.org/10.1016/j.ccm.2004.10.013
Alwi, I. (2014). Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi VI. In Interna Publishing.
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., MacE, S. E., McCracken, G. H., Moore, M. R., St Peter, S. D., Stockwell, J. A., & Swanson, J. T. (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clinical Infectious Diseases, 53(7), 25–76. https://doi.org/10.1093/cid/cir531
Caballero J, Rello J. 2011. Combination antibiotic therapy for community-acquired pneumonia. Ann Intensive Care.;1(1):1–7. https://doi.org/10.1186/2110- 5820-1-48
Damayanti, M., Olivianto, E., & Yunita, E. P. (2022). Effects of Rational Use of Antibiotics on Clinical Improvement of Pediatric Inpatients with Pneumonia. Indonesian Journal of Clinical Pharmacy, 11(2), 129–144. https://doi.org/10.15416/ijcp.2022.11.2.129
Depkes RI. (2016). Pharmaceutical Care Untuk Penyakit Infeksi Saluran Nafas. Direktorat Bina Farmasi Komunitas Dan Klinik, 1–23.
Dewi, I. A. T. (2024). Analisis efektivitas biaya penggunaan antibiotik pada pasien pneumonia anak di RSUD Sanjiwani Gianyar. Universitas Jember
Dinkes DKI Jakarta. (2023). Mengenal Penyakit Pneumonia. JakSehat. https://dinkes.jakarta.go.id/berita/read/mengenal-penyakit-pneumonia
Farida, Y. dan Soleqah, A.D. (2016). Identifikasi Potensi Interaksi Obat-Antibiotik pada Peresepan Pneumonia. JPSCR 1, 90-101.
Hammer, G. D., & McPhee, S. J. (2018). Pathophysiology of Disease 8th edition.
Hastuti, S., Islam, Z., Amaliah, Z., & Ruskar, D. (2022). Perbandingan biaya penggunaan ceftriaxone tunggal dan kombinasi pada pasien pneumonia komunitas. Pendipa Journal of Science Education, 6(2), 394–403
Howie S, Murdoch D. Global childhood pneumonia: the good news, the bad news and the ways ahead. Lancet Global Health. 2019;7(1):e4- 5.
Ikatan Dokter Anak Indonesia. (2009). Pedoman Pelayanan Medis. In Ikatan Dokter Indonesia (Vol. 25, Issue 122). https://doi.org/10.1136/adc.25.122.190
Irfan M, Farooqi J, Hasan R. (2013). Community acquired pneumonia. Curr Opin PulmMed. vol. 19. hlm. 111.
Izadi, M., Dadsetan, B., Najafi, Z., Jafari, S., Mazaheri, E., Dadras, O., Hajar, H., SeyedAhmad, A., Voltarelli, F. (2018). Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients. Recent Patents on Anti-Infective Drug Discovery, 13(3), 228–239.
Kementerian Kesehatan RI. (2022). Direktorat Pencegahan dan Pengendalian Penyakit Menular Kementerian Kesehatan. The Acceptance of Islamic Hotel Concept in Malaysia: A Conceptual Paper, 3(July), 1–119. http://download.garuda.kemdikbud.go.id/article.php?article=2652619&val=24585&title=KLASIFIKASI PNEUMONIA MENGGUNAKAN METODE SUPPORT VECTOR MACHINE
Kementrian Kesehatan Republik Indonesia. (2011). Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotika Kementrian Kesehatan Republik Indonesia.
Lipsett, S. C., Hall, M., Ambroggio, L., Hersh, A. L., Shah, S. S., Brogan, T. V., Gerber, J. S., Williams, D. J., Grijalva, C. G., Blaschke, A. J., & Neuman, M. I. (2021). Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia. Journal of Pediatrics, 229, 207-215.e1. https://doi.org/10.1016/j.jpeds.2020.10.005
Mani, C. S., & Murray, D. L. (2018). Acute Pneumonia and Its Complications. In: Principles and Practice of Pediatric Infectious Diseases. New York: 2018; 238-249.
Menteri Kesehatan Republik Indonesia. (2021). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Infeksi Dengue Anak dan Remaja. Pedoman Nasional Pelayanan Kedokteran, 67(MENTERI KESEHATAN), 1–67. https://yankes.kemkes.go.id/unduhan/fileunduhan_1660187378_126303.pdf
Menteri Kesehatan Republik Indonesia. (2019). Pedoman Tatalaksana Kemenkes. PEDOMAN NASIONAL PELAYANAN KEDOKTERAN TATA LAKSANA MALARIA, 1–64.
Nasidi, A. F. A., Sari, R. M., & Riyadi, R. A. (2024). Pengaruh pemberian antibiotik dosis tunggal atau kombinasi terhadap lama perawatan pasien pneumonia anak di RSI Sultan Agung Semarang. Universitas Islam Sultan Agung
Opovsky, E. Y., & Florin, T. A. (2020) .Community-Acquired Pneumonia in Childhood. Reference Module in Biomedical Sciences.
Permenkes RI. (2021). Pedoman Penggunaan Antibiotik. Permenkes RI, 1–97.
Rawls, S. M. (2014). Antibiotiks, β-Lactam. In Encyclopedia of the Neurological Sciences (pp. 207–209).
Rich, Z. C., & Melgar, T. A. (2023). Pediatric Pneumonia. Chronic Disease and Disability: The Pediatric Lung, 125–160. https://doi.org/10.1016/j.ijpam.2019.04.002
Sidiq, R., Ritawati, & Sitio, R. (2016). The Risk of Pneumonia among Toddlers in Lambatee, Aceh. National Public Health 2016; 69-73.
Silalahi, P. A. R., & Oktarlina, R. Z. (2025). Hubungan kualitas penggunaan antibiotik dengan lama rawat inap pada pasien pneumonia. Jurnal Farmasetis, 14(1), 21–30
Setyanto, D. B., Suardi, A. U., Setiawati, L., Triasih, R., & Yani, F. F. (2019). Pneumonia. Dalam: Pedoman Pelayanan Medis Jilid I. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia 2019; 250-255.
Scotta, M. C., Marostica, P. J. C., & Stein, R. T. (2019). Pneumonia in Children. In Kendig’s Disorders of the Respiratory Tract in Children (Ninth Edit). Elsevier Inc. https://doi.org/10.1016/B978-0-323-44887-1.00025-0
Shann, F. (1986). Etiology of severe pneumonia in children in developing countries. Pediatric Infectious Disease.
Utsman, P., & Karuniawati, H. (2020). Evaluasi Penggunaan Antibiotik pada Balita Penderita Pneumonia Rawat Inap di RSUD “Y” di Kota “X” Tahun 2016 Evaluation of Antibiotic Use in Toddler Patients of Pneumonia at “Y” Hospital of “X” City in 2016. Jurnal Farmasi Indonesia, 17(1), 45–53. http://journals.ums.ac.id/index.php/pharmacon
Wahyono, B. (2011). Pelayanan Puskesmas Berbasis Manajemen Terpadu Balita Sakit dengan Kejadian Pneumonia Balita. Jurnal Kesehatan Masyarakat, 7(1), 35–40.
Walker, R. (2021). Clinical Pharmacy and Therapeutics 5th edition. Elsevier.
WHO. (2021). Pneumonia. https://www.who.int/health-topics/pneumonia/#tab=tab_1
Widiyastuti, A., Kumala, S., Utami R, H., & Pratama, A. (2023). Hubungan Rasionalitas Penggunaan Antibiotik terhadap Luaran Klinis Pasien Pneumonia Komunitas Rawat Inap. Jurnal Kesehatan, 14(1), 109. https://doi.org/10.26630/jk.v14i1.3483
Yoshioka, D., Kajiwara, C., Ishii, Y., Umeki, K., Hiramatsu, K., Kadota, J. I., & Tateda, K. (2016). Efficacy of β-lactam-plus-macrolide combination therapy in a mouse model of lethal pneumococcal pneumonia. Antimicrobial Agents and Chemotherapy, 60(10), 6146–6154.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Lathvi Masyithah, Erischa Putri Diana, Dona Suzana
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
